These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21497460)

  • 21. Serotypes, antimicrobial susceptibility, and minimal inhibitory concentrations of Actionbacillus pleuropneumoniae isolated from slaughter pigs in Taiwan (2002-2007).
    Yang CY; Lin CN; Lin CF; Chang TC; Chiou MT
    J Vet Med Sci; 2011 Feb; 73(2):205-8. PubMed ID: 20948169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model.
    Tanigawa M; Sawada T
    J Vet Med B Infect Dis Vet Public Health; 2003 Nov; 50(9):436-42. PubMed ID: 14633197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade.
    Gutiérrez-Martín CB; del Blanco NG; Blanco M; Navas J; Rodríguez-Ferri EF
    Vet Microbiol; 2006 Jun; 115(1-3):218-22. PubMed ID: 16431040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
    Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
    BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotypes and antimicrobial resistance patterns of the recent Korean Actinobacillus pleuropneumoniae isolates.
    Yoo AN; Cha SB; Shin MK; Won HK; Kim EH; Choi HW; Yoo HS
    Vet Rec; 2014 Mar; 174(9):223. PubMed ID: 24552671
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro susceptibility of Actinobacillus pleuropneumoniae strains to 42 antimicrobial agents.
    Gutiérrez CB; Píriz S; Vadillo S; Rodríguez Ferri EF
    Am J Vet Res; 1993 Apr; 54(4):546-50. PubMed ID: 8484573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
    Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
    Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?
    Dorey L; Hobson S; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):517-529. PubMed ID: 28101885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology.
    Godinho KS; Keane SG; Nanjiani IA; Benchaoui HA; Sunderland SJ; Jones MA; Weatherley AJ; Gootz TD; Rowan TG
    Vet Ther; 2005; 6(2):113-21. PubMed ID: 16094559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation the kill rate and mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in a peristaltic pump model.
    Wang H; Liao C; Ding K; Zhang L; Wang L
    BMC Vet Res; 2024 Jun; 20(1):241. PubMed ID: 38831324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in the Antimicrobial Susceptibility of Actinobacillus pleuropneumoniae Isolates in a Pig, Within a Batch of Pigs, and Among Batches of Pigs from One Farm.
    Dayao DA; Dawson S; Kienzle MJ; Gibson JS; Blackall PJ; Turni C
    Microb Drug Resist; 2015 Aug; 21(4):491-6. PubMed ID: 25710484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the susceptibility of Actinobacillus pleuropneumoniae to antimicrobial agents in Quebec (1981-1986).
    Vaillancourt JP; Higgins R; Martineau GP; Mittal KR; Larivière S
    J Am Vet Med Assoc; 1988 Aug; 193(4):470-3. PubMed ID: 3170322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of tetracycline and erythromycin resistance in Actinobacillus pleuropneumoniae.
    Wasteson Y; Roe DE; Falk K; Roberts MC
    Vet Microbiol; 1996 Jan; 48(1-2):41-50. PubMed ID: 8701576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actinobacillus pleuropneumoniae is impaired by the garlic volatile allyl methyl sulfide (AMS) in vitro and in-feed garlic alleviates pleuropneumonia in a pig model.
    Becker PM; van Wikselaar PG; Mul MF; Pol A; Engel B; Wijdenes JW; van der Peet-Schwering CM; Wisselink HJ; Stockhofe-Zurwieden N
    Vet Microbiol; 2012 Jan; 154(3-4):316-24. PubMed ID: 21824734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCR-based identification of serotype 2 isolates of Actinobacillus pleuropneumoniae biovars I and II.
    Hüssy D; Schlatter Y; Miserez R; Inzana T; Frey J
    Vet Microbiol; 2004 Apr; 99(3-4):307-10. PubMed ID: 15066734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae.
    Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R
    Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Carbonyl Cyanide Chlorophenylhydrazone on Intrabacterial Concentration and Antimicrobial Activity of Amphenicols against Swine Resistant Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Rattanapanadda P; Kuo HC; Chang SK; Tell LA; Shia WY; Chou CC
    Vet Res Commun; 2022 Sep; 46(3):903-916. PubMed ID: 35322371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.